TRACT Therapeutics
Chicago, US · Delaware corporation
Find your way into TRACT Therapeutics
91 people in our graph share verified history with the TRACT Therapeutics team — schools, employers, funds. One of them is your warm intro.
Christopher Mixsonunlockedknows Gretchen Johnson · together at Western Illinois University (overlapped)
×8knows the team · via Northern Illinois University
×3knows the team · via Western Illinois University
Founders & leadership
PC
Peter CourossiExecutive
GJ

Gretchen JohnsonExecutiveGretchen Johnson is an executive officer and director at TRACT Therapeutics with over 25 years of experience in biotechnology and life sciences, including work on biologic and medical device development and commercialization.
Board
JL
Joseph LeventhalBoard director
NR
Norbert RiedelBoard director
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2019
▶$15MraisedApr 2019 · 1 investors · BiotechnologyRule 506(b)
▶$15MraisedApr 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LeventhalDirector
- Peter CourossiExecutive Officer, Director
- Gretchen JohnsonExecutive Officer, Director
- Norbert RiedelDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has TRACT Therapeutics raised?
- TRACT Therapeutics has disclosed $15M raised across 1 round.
- Where is TRACT Therapeutics headquartered?
- TRACT Therapeutics is headquartered in Chicago, US.
